XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 72 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,292,000 | -39.9% | 2,976,180 | -0.1% | 0.00% | – |
| Q2 2021 | $12,131,000 | -2.1% | 2,980,367 | +8.5% | 0.00% | – |
| Q1 2021 | $12,385,000 | +4.3% | 2,746,045 | +13.8% | 0.00% | – |
| Q4 2020 | $11,872,000 | -10.0% | 2,413,048 | +8.4% | 0.00% | – |
| Q3 2020 | $13,196,000 | +128.9% | 2,225,405 | +2.7% | 0.00% | – |
| Q2 2020 | $5,765,000 | +74.7% | 2,167,244 | +28.1% | 0.00% | – |
| Q1 2020 | $3,299,000 | -64.5% | 1,691,837 | +28.4% | 0.00% | – |
| Q4 2019 | $9,292,000 | -27.0% | 1,318,060 | +1.8% | 0.00% | – |
| Q3 2019 | $12,725,000 | -8.8% | 1,294,529 | +6.2% | 0.00% | -100.0% |
| Q2 2019 | $13,947,000 | +22.1% | 1,219,153 | +7.1% | 0.00% | – |
| Q1 2019 | $11,425,000 | +104.7% | 1,137,944 | +246.6% | 0.00% | – |
| Q4 2018 | $5,581,000 | +24.5% | 328,309 | +28.7% | 0.00% | – |
| Q3 2018 | $4,484,000 | +846.0% | 255,064 | +920.3% | 0.00% | – |
| Q2 2018 | $474,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |